Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secukinumab vs placebo in active non-radiographic axial spondyloarthritis (Japan, phase 3)
jRCT2080223230Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 3, randomised, double-blind trial in non-radiographic axial spondyloarthritis (nr-axSpA) comparing Secukinumab with Placebo (2 arms). Started Jun 2016; status: completed.
02
Drugs
secukinumab
03
Conditions
non-radiographic axial spondyloarthritis (nr-axSpA)
Beyond the preview
Go deeper on jRCT2080223230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223230.